Have a personal or library account? Click to login
TRUS-MR Fusion Biopsy of the Prostate: Radiological and Histological Correlation Cover

TRUS-MR Fusion Biopsy of the Prostate: Radiological and Histological Correlation

Open Access
|Nov 2016

References

  1. Woodrum DA Kawashima A Gorny KR Mynderse LA Targeted prostate biopsy and MR-guided therapy for prostate cancer [Epub ahead of print] Abdom Radiol (NY) 2016 Feb 24
  2. Loeb S Folkvaljon Y Robinson D Makarov DV Bratt O Garmo H Stattin P Immediate versus delayed prostatectomy: Nationwide population-based study Scand J Urol 2016 Apr 12 1 9 10.3109/21681805.2016.1166153
  3. Villers A Lemaitre L Haffner J Puech P Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: Implications for focal therapy and active surveillance Curr Opin Urol 2009 19 3 274 282 10.1097/MOU.0b013e328329a2ed
  4. Pinto PA Chung PH Rastinehad AR Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging J Urol 2011 186 4 1281 1285 10.1016/j.juro.2011.05.078
  5. Rais-Bahrami S Siddiqui MM Turkbey B Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer J Urol 2013 190 5 1721 1727 10.1016/j.juro.2013.05.052
  6. Costa DN Pedrosa I Donato F Jr. Roehrborn CG Rofsky NM MR imaging-transrectal US fusion for targeted prostate biopsies: Implications for diagnosis and clinical management Radiographics 2015 35 3 696 708 10.1148/rg.2015140058
  7. Haider MA van der Kwast TH Tanguay J Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer AJR Am J Roentgenol 2007 189 2 323 328 10.2214/AJR.07.2211
  8. Hoeks CM Barentsz JO Hambrock T Prostate cancer: Multiparametric MR imaging for detection, localization, and staging Radiology 2011 261 1 46 66 10.1148/radiol.11091822
  9. Engelbrecht MR Huisman HJ Laheij RJ Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging Radiology 2003 229 1 248 254 10.1148/radiol.2291020200
  10. Pickles MD Gibbs P Sreenivas M Turnbull LW Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T J Magn Reson Imaging 2006 23 2 130 134 10.1002/jmri.20477
  11. Gibbs P Liney GP Pickles MD Zelhof B Rodrigues G Turnbull LW Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla Invest Radiol 2009 44 9 572 576 10.1097/RLI.0b013e3181b4c10e
  12. Woodfield CA Tung GA Grand DJ Pezzullo JA Machan JT Renzulli JF 2nd Diffusion-weighted MRI of peripheral zone prostate cancer: Comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy AJR Am J Roentgenol 2010 194 4 W316 322 10.2214/AJR.09.2651
  13. deSouza NM Riches SF Vanas NJ Diffusion-weighted magnetic resonance imaging: A potential non-invasive marker of tumour aggressiveness in localized prostate cancer Clin Radiol 2008 63 7 774 782 10.1016/j.crad.2008.02.001
  14. Image of Artemis Eigen Fusion Official Eigen Website. http://www.eigen.com/products/artemis.shtml. Published 2013. Accessed April 17, 2016
  15. Marks L Ward A Gardi L Tracking of prostate biopsy sites using a 3D ultraound device (Artemis) J Urol 2010 183 4 e832 10.1016/j.juro.2010.02.2242
  16. Epstein JI Zelefsky MJ Sjoberg DD Contemporary prostate cancer grading system: A validated alternative to the Gleason score Eur Urol 2016 69 3 428 435 10.1016/j.eururo.2015.06.046
  17. Siddiqui MM Rais-Bahrami S Turkbey B Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer JAMA 2015 313 4 390 397 10.1001/jama.2014.17942
  18. Nakano Junqueira VC Zogbi O Cologna A Is a visible (hypoechoic) lesion at biopsy an independent predictor of prostate cancer outcome? Ultrasound Med Biol 2012 38 10 1689 1694 10.1016/j.ultrasmedbio.2012.06.006
  19. Natarajan S Marks LS Margolis DJ Clinical application of a 3D ultrasound-guided prostate biopsy system Urol Oncol 2011 29 3 334 342 10.1016/j.urolonc.2011.02.014
  20. Wu J Ji A Xie B Is magnetic resonance/ultrasound fusion prostate biopsy better than systematic prostate biopsy? An updated meta- and trial sequential analysis Oncotarget 2015 6 41 43571 43580
  21. Wysock JS Mendhiratta N Zattoni F Predictive value of negative 3T multiparametric prostate MRI on 12 core biopsy results BJU Int 2016 118 4 515 520 10.1111/bju.13427
  22. Multiple authors American College of Radiology Web site http://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/PIRADS/PIRADS%20V2.pdf. Published 2015. Accessed October 15, 2016
  23. Delongchamps NB Rouanne M Thierry F Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: Combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging BJUI 2011 107 09 1411 1418
  24. de Rooij M Crienen S Witjes JA Barentsz JO Rovers MM Grutters JP Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: A modelling study from a health care perspective Eur Urol 2014 66 3 430 436 10.1016/j.eururo.2013.12.012
  25. UCLA David Geffen School of Medicine Web site http://casit.ucla.edu/images/Lase%20Pic%20V3.jpg. Published 2009. Accesed April 5, 2016
Language: English
Published on: Nov 24, 2016
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2016 Michel Lavaerts, Liesbeth De Wever, Els Vanhoutte, Frederik De Keyzer, Raymond Oyen, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.